Insulet FY2026 expected to be more than $6.21 vs $6.36 Est; Raises FY2026 Sales Guidance from $3.250B-$3.304B to $3.277B-$3.331B vs $3.307B Est

Benzinga Newsdesk www.benzinga.com Positive 92.4%